The U.S. Drug Enforcement Administration (DEA) will host a webinar on June 20, 2017. The webinar will cover the updated Import and Export regulations for Controlled Substances and Listed Chemicals. The U.S. Customs and Border Protection (CBP) will also be in attendance.
Compliance Solutions (CS) News
CS is the official news source and blog of GCSG. Read CS for expert opinion on compliance management systems, audits, due diligence, regulatory developments, events, news, opinions, links to compliance articles, and more.
The Drug Enforcement Administration (DEA) published a final rule on January 30, 2017 (81 FR 8688-8689) which delays the effective date of their December 30, 2016 final rule (81 FR 96992-97044) that amended export/import requirements for Tableting and Encapsulating machines, Controlled Substances, and Listed Chemicals as well as domestic transactions for Listed Chemicals and Tableting and Encapsulating Machines.
The federal register notice states the temporary delay allows "Department of Justice officials an opportunity to review any potential questions of fact, law and policy raised by this regulation, consistent with the Chief of Staff's memorandum of January 20, 2017." Click here for the January 20, 2017 Memorandum for the Heads of Executive Departments and Agencies from Reince Priebus, Assistant to the President and Chief of Staff.
This final rule is effective January 30, 2017 and temporarily delays the December final rule until March 21, 2017. In addition, the required compliance date has now been moved from June 28, 2017 until July 31, 2017.
On Friday, December 30, 2016 the Drug Enforcement Administration (DEA) published a Final Rule (81 FR 96992-97044) that updates their regulations for the import and export of tableting and encapsulating machines, controlled substances, and listed chemicals. The rule also updates their regulations related to the required reports for domestic transactions of listed chemicals, gamma-hydroxybutyric acid, and tableting and encapsulating machines.
The rule becomes effective on January 30, 2017. Compliance with the final rule is required by June 28, 2017.
For more information on the specific changes included in this final rule, click here to read the earlier post by GCSG related to the proposed rule.
On Monday, December 12, 2016 the Drug Enforcement Administration (DEA) published a proposed rule (81 FR 89402-89407) which would designate the chemical Alpha-Phenylacetoacetonitrile (APAAN) and its salts, optical isomers, and salts of optical isomers, as a List I Chemical. APAAN can be used in the illicit manufacture of phenylacetone, methamphetamine, and amphetamine. The DEA did not propose a regulatory threshold for APAAN, so all transactions of APAAN would be regulated.
Designation as a List I Chemical will require manufacturers, importers, exporters, and distributors of APAAN to obtain a registration as well as comply with all applicable security, know-your-customer, import, export, recordkeeping, and reporting requirements associated with a List I Chemical.
APAAN also goes by: 1-cyano-1-phenylpropan-2-one; 2-phenylacetoacetonitrile, 2-acetyl-2-phenylacetonitrile; alpha-acetyl-benzene acetonitrile; phenyl aceto-acetonitrile; [alpha] - acetylphenylacetonitrile; and 3-oxo-2-phenylbutanenitrile and it's CAS Number is 4468-48-8.
If you are a manufacturer, importer, exporter, or distributor of APAAN and would like more information on how this may impact your operations, please contact GCSG here.